ARTICLE

Global Access Program

Committed to Viral Hepatitis

 

Hepatitis B and C are among the most common viral infections in the world. At least 263 million worldwide in 2017 – are carriers of hepatitis B or C virus infections, which can remain asymptomatic for decades.1,2

95% of people living with viral

hepatitis do not know.


In 2016, the World Health Assembly adopted WHO’s first

“Global Health Sector Strategy on viral hepatitis,”

with elimination as its overarching vision.

Globally, 263 million

persons are infected

Vision, goal and targets

 

VISION

A world where viral hepatitis transmission is halted

and everyone living with viral hepatitis has access to

safe, affordable and effective prevention, care and

treatment services.

 

GOAL

Eliminate viral hepatitis as a major public health

threat by 2030.

 

TARGETS

Between 6 and 10 million infections are

reduced to less than 1 million by 2030;

1.4 million deaths reduced to less than 500 000 by 2030.

90% reduction in new cases of chronic hepatitis B and C by 2030

Global Vision

 

A world where viral hepatitis transmission is halted and everyone living with viral hepatitis has access to safe, affordable and effective prevention, care and treatment services

 

Goal

 

Eliminate viral hepatitis as a major public health threat by 2030
 
 
RMD-HPV-Global-Vision-And-Goal
Hepatitis_global_vision

72 countries projected to meet the 2030 target
of ≤0.1% HBsAg prevalence among 5-Year-Olds

 

Roche committed to the elimination of hepatitis

 

To advance global efforts and eliminate viral hepatitis, Roche is committed
to this motivational program underscoring our ongoing efforts to provide
life-saving diagnostics, and supports governments aiming to cure people
of hepatitis.

Roche is a leader in viral load testing and is dedicated to enabling
improved patient management by delivering innovative, high-quality
diagnostic solutions where they are needed most.
Hepatitis_table

References

 

  1. World Health Organization. Hepatitis C Fact Sheet Updated July 2016. Last accessed July 2016 at http://www.who.int/mediacentre/factsheets/fs164/en/
  2. World Health Organization. Global Hepatitis Report 2017. Last accessed May 2017 at http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1
  3. World Health Organization. World Hepatitis Day. Last accessed July 2016 at http://www.who.int/campaigns/hepatitis-day/2016/event/en/
  4. Polaris Observatory Collaborators. Lancet Gastroenterol Hepatol. 2018